Adrian P Mansini

8PUBLICATIONS
20CO-AUTHORS
Molecular targetsNaturopathyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
B7-H6/NKp30 Axis in Melanoma: Translational Rationale, Evidence Gaps, and Therapeutic Considerations.

|May 13, 2026
CD24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic Target.

|Mar 18, 2026
Review of Low-Dose Naltrexone for Hailey-Hailey Disease Suggests Lack of Benefit in Dose Escalation.

Yulu Wang, Haley R Gainer, Claudia Lasalle

|Oct 16, 2025
Sentinel Lymph Node Biopsy in Melanoma: Overview and Updates.

Adrian Mansini, Shah Aarohi, Mario Della Mura

|Sep 13, 2025
Role of Androgen Receptor in Melanoma: Mechanisms of Tumor Progression, Immune Evasion, and Therapeutic Implications.

Claudia Lasalle, Yulu Wang, Maria T Morales

|Dec 22, 2023
Myeloid differentiation factor-2/LY96, a potential predictive biomarker of metastasis and poor outcomes in prostate cancer: clinical implications as a potential therapeutic target.

Marina G Ferrari, Alexis P Jimenez-Uribe, Li Wang

Pageof 2

Frequent Collaborators

3 joint publications

Claudia Lasalle

2 joint publications

Luke Hoeppner

2 joint publications

Jindan Yu

2 joint publications

Nicole C Nowak